These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20063132)

  • 1. Rituximab therapy for refractory immune thrombocytopenic purpura in elder patients.
    Hangaishi A; Takahashi T; Masuda A; Okada S; Kandabashi K; Kurokawa M
    Int J Hematol; 2010 Mar; 91(2):336-7. PubMed ID: 20063132
    [No Abstract]   [Full Text] [Related]  

  • 2. Slow responses to standard dose rituximab in immune thrombocytopenic purpura.
    Kelly K; Gleeson M; Murphy PT
    Haematologica; 2009 Mar; 94(3):443-4; author reply 444-5. PubMed ID: 19252177
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment with rituximab of refractory idiopathic thrombocytopenic purpura in a patient with Kabuki syndrome.
    Torii Y; Yagasaki H; Tanaka H; Mizuno S; Nishio N; Muramatsu H; Hama A; Takahashi Y; Kojima S
    Int J Hematol; 2009 Sep; 90(2):174-176. PubMed ID: 19662467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.
    Pohlen M; Sargin B; Zicholl S; Bisping G; Müller-Tidow C; Berdel WE; Mesters R; Koschmieder S
    Eur J Haematol; 2010 Apr; 84(4):362-4. PubMed ID: 20050881
    [No Abstract]   [Full Text] [Related]  

  • 5. Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
    Zaja F; Battista ML; Pirrotta MT; Palmieri S; Montagna M; Vianelli N; Marin L; Cavallin M; Bocchia M; Defina M; Ippoliti M; Ferrara F; Patriarca F; Avanzini MA; Regazzi M; Baccarani M; Isola M; Soldano F; Fanin R
    Haematologica; 2008 Jun; 93(6):930-3. PubMed ID: 18403395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).
    Tran H; Brighton T; Grigg A; McRae S; Dixon J; Thurley D; Gandhi MK; Truman M; Marlton P; Catalano J
    Br J Haematol; 2014 Oct; 167(2):243-51. PubMed ID: 25041261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Good response to treatment with rituximab in a child with refractory idiopathic thrombocytopenic purpura].
    Fríguls-Francitorra B; Almazán-Castro F; Manchón GJ
    Med Clin (Barc); 2006 Sep; 127(12):478-9. PubMed ID: 17040639
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of autoantibody-producing plasma cells in immune thrombocytopenic purpura refractory to rituximab.
    Kuwana M; Iki S; Urabe A
    Am J Hematol; 2007 Sep; 82(9):846-8. PubMed ID: 17506067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab.
    Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N
    Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of rituximab in resistant thrombocytopenic purpura].
    Zambrano-Velarde MA; de la O-Peña D; Chávez-Peña Q; Bedolla-Barajas M
    Rev Med Inst Mex Seguro Soc; 2012; 50(2):203-8. PubMed ID: 22882991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of rituximab in refractory autoimmune thrombocytopenia following an autologous stem cell transplant.
    Price S; Cumpston A; Altaha R
    Hematology; 2006 Feb; 11(1):43-4. PubMed ID: 16522548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment in refractory idiopathic thrombocytopenic purpura in children.
    Roganovic J
    Eur J Pediatr; 2005 May; 164(5):334. PubMed ID: 15711954
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.
    Gómez-Almaguer D; Solano-Genesta M; Tarín-Arzaga L; Herrera-Garza JL; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Jaime-Pérez JC
    Blood; 2010 Dec; 116(23):4783-5. PubMed ID: 20841509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rituximab is effective for selected patients with chronic steroid-refractory immune thrombocytopenic purpura.
    Lalayanni C; Stavroyianni N; Saloum R; Tsompanakou A; Anagnostopoulos A
    Hematology; 2004 Aug; 9(4):287-9. PubMed ID: 15621736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.
    Stasi R; Pagano A; Stipa E; Amadori S
    Blood; 2001 Aug; 98(4):952-7. PubMed ID: 11493438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura.
    Ojeda-Uribe M; Federici L; Wolf M; Coppo P; Veyradier A
    Transfusion; 2010 Mar; 50(3):733-5. PubMed ID: 20609201
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for patients with idiopathic thrombocytopenic purpura.
    Peñalver FJ; Cabrera JR
    Ann Intern Med; 2007 Aug; 147(4):281; author reply 281-2. PubMed ID: 17709765
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose rituximab in adult patients with primary immune thrombocytopenia.
    Zaja F; Vianelli N; Volpetti S; Battista ML; Defina M; Palmieri S; Bocchia M; Medeot M; De Luca S; Ferrara F; Isola M; Baccarani M; Fanin R
    Eur J Haematol; 2010 Oct; 85(4):329-34. PubMed ID: 20546023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.